Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

Biotechnology

Healthcare
$95.51 +3.81%

+$3.89 today

Market cap
$6.24B
Beta
0.51
P/E (TTM)
-7.8
EPS (TTM)
-$13.57
52W Low $47.89High $114.99

Volume 0.78M

Average 0.95M

Balance Sheet

Inspect the capital base behind the business.

Assets

$842.81M

FY 2025 · Annual

+25.7% YoY

Liabilities

$528.12M

FY 2025 · Annual

+18.6% YoY

Equity

$314.69M

FY 2025 · Annual

+39.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents31.34M28M286.33M222.5M296.68M
Short-term Investments125.2M123.72M057.81M86.64M
Net Receivables4.37M23.99M67.97M78.29M123.33M
Inventory1.51M5.57M22.31M22.4M24.89M
Other Current Assets4.17M8.95M10.94M11.78M18.14M
Total Current Assets166.59M190.23M387.54M392.79M549.68M
Property, Plant & Equipment (Net)2.55M2.35M1.99M9.81M10.6M
Goodwill00000
Intangible Assets18.74M58.95M252.93M249.82M260.92M
Long-term Investments4.98M0012.53M8.11M
Tax Assets00000
Other Non-current Assets101.79M101.38M4.17M5.81M13.5M
Total Non-current Assets128.06M162.68M259.08M277.97M293.13M
Total Assets294.65M352.91M646.62M670.75M842.81M
Account Payables9.17M8.69M7.42M14.62M9.61M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities11.98M15.75M20.94M32.25M47.28M
Total Current Liabilities42.6M64.73M87.06M126.55M205.8M
Long-term Debt00306.42M308.08M309.8M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)129.92M140.35M000
Other Non-current Liabilities17K4.53M3.85M2.51M5.01M
Total Non-current Liabilities131.84M146.14M310.89M318.56M322.32M
Total Liabilities174.44M210.87M397.95M445.11M528.12M
Common Stock3K4K5K5K5K
Retained Earnings(257.16M)(392.82M)(556.24M)(644.18M)(667.54M)
Accumulated OCI(35K)(217K)1.64M(373K)351K
Other Stockholders Equity00000
Minority Interest00000
Total Equity120.21M142.04M248.67M225.64M314.69M
Total Debt2.61M2.19M308.14M317.76M319.45M
Net Debt(28.73M)(25.82M)21.82M95.26M22.77M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$330.7M
Short-term Investments$107.6M
Receivables$145.4M
Inventory$25.8M
Other Current$26.9M
Total Current Assets$636.3M
PP&E (Net)$14.3M
Intangible Assets$247.4M
Long-term Investments$123.0M
Other Non-current$24.0M
Total Non-current Assets$408.7M
Total Assets$1.0B

Analysis

Selected assets total $1.0B for Latest. The largest visible component is Cash & Equivalents at $330.7M, about 31.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
10-QQuarterly reportNov 3, 2026
8-KCurrent reportNov 3, 2026

How much cash does MIRM have?

Mirum Pharmaceuticals, Inc. (MIRM) reported $296.68M in cash and equivalents in fiscal 2025.

How much debt does MIRM carry?

Mirum Pharmaceuticals, Inc. (MIRM) reported $319.45M of total debt, with net debt of $22.77M.